<DOC>
	<DOCNO>NCT00994812</DOCNO>
	<brief_summary>The purpose study determine whether metformin may improve pregnancy rate , decrease miscarriage rate complication pregnancy , toxemia gestational diabetes , woman polycystic ovary syndrome ( PCOS ) .</brief_summary>
	<brief_title>The Effects Metformin Pregnancy Miscarriage Rates Polycystic Ovary Syndrome ( PCOS )</brief_title>
	<detailed_description>Women PCOS represent 5-10 % general female population one third woman treat infertility . Thus , development new therapy improve efficiency ovulation induction treatment outcome pregnancy , reduce long-term risk syndrome would bring important health benefit . The central role play insulin resistance hyperinsulinemia PCOS - cause hyperandrogenism , premature follicular atresia , anovulation , oligo-amenorrhea anovulatory infertility - lead use insulin-lowering drug treatment syndrome . The studied agent metformin , biguanide antihyperglycemic drug use treat Type 2 diabetes mellitus . It show improve significantly hyperinsulinemia insulin resistance , decrease androgen level , improve menstrual pattern , alone addition clomiphene citrate , induce ovulation improve pregnancy rate woman PCOS study ( 1,2 ) . Metformin may also decrease risk early spontaneous miscarriage gestational diabetes PCOS ( 3-6 ) . Two recent RCTs , however , show beneficial effect metformin compare placebo regard rate pregnancy , miscarriage life birth woman PCOS ( 7,8 ) . Our hypothesis metformin may improve pregnancy rate decrease miscarriage occurrence complication pregnancy , toxemia gestational diabetes , woman PCOS . This multicenter randomize placebo-controlled study conduct five University Hospitals Finland ( Oulu , Kuopio , Helsinki , Tampere Turku ) . Blood sample draw oral glucose tolerance test ( OGTT ) do 3 month treatment , treatment placebo/metformin continue another 6 month ' period together appropriate infertility treatment . If pregnancy occur , OGTT do 7-8 week pregnancy placebo/metformin treatment continue 12 week pregnancy . The study already start estimate continue least end 2009 . Power analysis indicated minimum 60 pregnant patient need group decrease risk miscarriage 44 % normal 15 % .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1. age &lt; 40 year entry 2 . BMI &gt; 19 kg/m2 3 . Infertility last &gt; 1 year 4 . Criteria PCOS define ESHRE/ASRM : least two follow finding : polycystic ovary show vaginal ultrasonography ( 12 subcapsular follicle 38 mm diameter one plane ovary ) oligomenorrhea amenorrhea clinical manifestation hyperandrogenism hirsutism score &gt; 7 accord Ferriman Gallwey ( Ferriman &amp; Gallwey 1961 ) and/or elevate serum testosterone level ( &gt; 2.7 nmol/l ) . 1. diabetic subject 2. alcohol user 3. active liver disease ( ALAT &gt; +2 SD upper normal value i.e. &gt; 100IU/l ) 4. hormonal drug 5. past present cardiac failure ( NYHA IIV ) 6. liver renal failure ( SCreatinine normal value ie.124 umol/l ) 7. pregnancy lactation 8. hypersensitivity metformin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>PCOS</keyword>
	<keyword>Metformin</keyword>
	<keyword>Miscarriage</keyword>
	<keyword>Infertility</keyword>
	<keyword>Complications pregnancy</keyword>
</DOC>